Concepedia

Mina Aikawa

MA

Statistics

Publications

8

Citations

582

H-Index

8

Active since

1998

Affiliations

Novartis (Switzerland)(Current)

Collaborative Drug Discovery (United States)

Molecular Oncology (United States)

Mina Aikawa is an author at Novartis (Switzerland) specializing in signal transduction, cell signaling, and pharmacology.

Publications per year

1998–2016

8

Publications

8

WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial Cells

Jackie Papkoff, Mina Aikawa · Biochemical and Biophysical Research Communications · 1998 · 184 citations

, , +16

Identification of a Wnt-Responsive Signal Transduction Pathway in Primary Endothelial Cells

Meredith Wright, Mina Aikawa, Wayne Szeto et al. · Biochemical and Biophysical Research Communications · 1999 · 123 citations

, , +14

A secreted Frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates Wnt-1 signaling

Steve Dennis, Mina Aikawa, Wayne Szeto et al. · Journal of Cell Science · 1999 · 88 citations

, , +14

Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors

Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa et al. · Journal of Medicinal Chemistry · 2008 · 76 citations · Full text

, , +13

Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors

Hong Xiang, Judith A. Fox, Klára Tótpál et al. · Oncogene · 2002 · 50 citations

, , +17

1–5 of 8